Literature DB >> 19109017

(-)-Cercosporamide derivatives as novel antihyperglycemic agents.

Akihiro Furukawa1, Tsuyoshi Arita, Susumu Satoh, Kazushi Araki, Masanori Kuroha, Jun Ohsumi.   

Abstract

In our exploratory campaign for an antihyperglycemic agent with a novel mechanism of action, (-)-Cercosporamide 1, which is known as an antifungal agent, showed a potent plasma glucose lowering effect in hyperglycemic KK/Ta mice. The trouble was that it was accompanied by a decrease in food intake and a loss of body weight. We synthesized some (-)-Cercosporamide derivatives and succeeded to separate these actions. N,O-ketal type derivatives, especially compound 10, had the most potent plasma glucose lowering effect without affecting the food consumption or body weight.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109017     DOI: 10.1016/j.bmcl.2008.12.035

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Enantioselective Synthesis of Fluoro-Dihydroquinazolones and -Benzooxazinones by Fluorination-Initiated Asymmetric Cyclization Reactions.

Authors:  Kenichi Hiramatsu; Takashi Honjo; Vivek Rauniyar; F Dean Toste
Journal:  ACS Catal       Date:  2015-12-04       Impact factor: 13.084

2.  MNK2 deficiency potentiates β-cell regeneration via translational regulation.

Authors:  Christos Karampelias; Kathleen Watt; Charlotte L Mattsson; Ángel Fernández Ruiz; Habib Rezanejad; Jiarui Mi; Xiaojing Liu; Lianhe Chu; Jason W Locasale; Gregory S Korbutt; Meritxell Rovira; Ola Larsson; Olov Andersson
Journal:  Nat Chem Biol       Date:  2022-06-13       Impact factor: 16.174

3.  Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.

Authors:  Viet Hung Dao; Isabelle Ourliac-Garnier; Cédric Logé; Florence O McCarthy; Stéphane Bach; Teresinha Gonçalves da Silva; Caroline Denevault-Sabourin; Jérôme Thiéfaine; Blandine Baratte; Thomas Robert; Fabrice Gouilleux; Marie Brachet-Botineau; Marc-Antoine Bazin; Pascal Marchand
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

4.  A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in Mice.

Authors:  Tarjani Shukla; June Bryan de la Peña; John M Perish; Jonathan E Ploski; Craig R Stumpf; Kevin R Webster; Catherine A Thorn; Zachary T Campbell
Journal:  Neurotherapeutics       Date:  2020-10-01       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.